| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| E9PML4 | Proadrenomedullin N-20 terminal peptide; | ADM; | NULL | 83 | human |
| A0A024RAL6 | MADS box transcription enhancer factor 2, polypeptide C (Myocyte enhancer factor 2C), isoform CRA_a; | MEF2C; | NULL | 465 | human |
| A0A024R5Y5 | Sorting nexin 22, isoform CRA_a; | SNX22; | NULL | 193 | human |
| D3DWH5 | HCG1820375, isoform CRA_a; | NULL | NULL | 111 | human |
| Q15HF4 | Cytochrome c oxidase subunit 1; EC 1.9.3.1; | COX1; | NULL | 513 | human |
| G5E9Y6 | Spermatogenesis associated 4, isoform CRA_a; Spermatogenesis-associated protein 4; | SPATA4; | NULL | 132 | human |
| A0A024R1B6 | HCG2042868, isoform CRA_b; | NULL | NULL | 138 | human |
| B7Z5B4 | Carcinoembryonic antigen-related cell adhesion molecule 3, isoform CRA_c; cDNA FLJ51937, highly similar to Carcinoembryonic antigen-related celladhesion molecule 6; | CEACAM3; | NULL | 177 | human |
| C4N361 | KIR3DL1; KIR3DL1/S1; | KIR3DL1; | NULL | 444 | human |
| Q9H4L3 | Breast and ovarian cancer susceptibility protein 2; Breast cancer 2 tumor suppressor; Fragment; | BRCA2; | NULL | 56 | human |
| D3DTC2 | Acyltransferase like 2, isoform CRA_a; | AYTL2; | XP_005248430.1; | 486 | human |
| Q5MJ33 | Protection of telomeres protein 1; Protection of telomeres protein 1 variant 4; | POT1; | NP_001036059.1; | 45 | human |
| E9PKI7 | DIS3-like exonuclease 1; | DIS3L; | NULL | 55 | human |
| B0QYG7 | Protein kinase C and casein kinase substrate in neurons protein 2; Fragment; | PACSIN2; | NULL | 152 | human |
| U5YWI5 | ATP synthase subunit a; | ATP6; | NULL | 226 | human |
| H0YEC2 | CKLF-like MARVEL transmembrane domain-containing protein 1; Fragment; | CMTM1; | NULL | 131 | human |
| W8CSR0 | NADH-ubiquinone oxidoreductase chain 3; EC 1.6.5.3; Fragment; | ND3; | NULL | 62 | human |
| Q305A3 | ATP synthase subunit a; | ATP6; | NULL | 226 | human |
| D6RBF7 | Nucleoporin p54; | NUP54; | NULL | 102 | human |
| B5BU46 | Caspase 8 isoform C; | CASP8; | NULL | 464 | human |
